Treatment of low-risk gestational trophoblastic neoplasia comparing biweekly eight-day Methotrexate with folinic acid versus bolus-dose Actinomycin-D, among Brazilian women

Treatment of low-risk gestational trophoblastic neoplasia comparing biweekly eight-day Methotrexate with folinic acid versus bolus-dose Actinomycin-D, among Brazilian women

PURPOSE: To compare two single-agent chemotherapy (ChT) regimens evaluating, in first-line treatment, response and side effects and, in final single-agent treatment, the outcomes, among Brazilian patients with low-risk gestational trophoblastic neoplasia (GTN), according to International Federation...

Full description

Bibliographic Details
Main Authors: Elza Maria Hartmann Uberti, Maria do Carmo Fajardo, Adriana Gerhardt Vieira da Cunha, Sirlene Soares Frota, Antônio Braga, Antonio Celso Koehler Ayub
Format: Article
Language:English
Published: Federação Brasileira das Sociedades de Ginecologia e Obstetrícia 2015-06-01
Series:Revista Brasileira de Ginecologia e Obstetrícia
Subjects:
Methotrexate/administration & dosage
Methotrexate/therapeutic use
Methotrexate/adverse effects
Dactinomycin/administration & dosage
Dactinomycin/therapeutic use
Dactinomycin/adverse effects
Gestational trophoblastic disease/drug therapy
Online Access:http://www.scielo.br/pdf/rbgo/v37n6/0100-7203-rbgo-37-06-00258.pdf

Internet

http://www.scielo.br/pdf/rbgo/v37n6/0100-7203-rbgo-37-06-00258.pdf

Similar Items